Sensus Healthcare to Present at the 29th Annual ROTH Conference

Tuesday, March 7, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

BOCA RATON, Fla., March 7, 2017 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing

in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company's chief executive officer, will present a corporate overview
at the 29th Annual ROTH Conference on Wednesday, March 15th  at 8:30 a.m. Pacific time.  The conference will be held at the Ritz-Carlton, Laguna Niguel in Dana Point, Calif. from March 13th  through 15th.

To listen to the presentation, investors may visit Sensus Healthcare's website at www.sensushealthcare.com or by clicking here.

An archived audio of the presentation and accompanying slides will also be available on the company's website for 90 days.

About Sensus HealthcareSensus Healthcare, Inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients.

For further information, please visit http://www.sensushealthcare.com

Contacts:Investors LHAKim Sutton Golodetz(212) [email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-the-29th-annual-roth-conference-300419374.html

SOURCE Sensus Healthcare, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store